Reuters logo
BRIEF-Lipocine says ‍FDA assigned a new prescription drug user fee act goal date of May 8, 2018 for Tlando​
November 17, 2017 / 1:30 PM / in a month

BRIEF-Lipocine says ‍FDA assigned a new prescription drug user fee act goal date of May 8, 2018 for Tlando​

Nov 17 (Reuters) - Lipocine Inc

* U.S. FDA extends review for Tlando™; advisory committee meeting date of January 10, 2018 remains unchanged

* Lipocine Inc - ‍FDA has assigned a new prescription drug user fee act goal date of May 8, 2018 for Tlando​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below